Correlation between serum miR-1-3p and miR-155 levels and sarcopenia in elderly patients with type 2 diabetic nephropathy and construction of a prediction model
CSTR:
Author:
Affiliation:

(Department of Nephrology, Qinhuangdao First Hospital, Qinhuangdao 066000, Hebei Province, China)

Clc Number:

Fund Project:

This work was supported by the Project of Qinhuangdao Science and Technology Research and Development(202401AO61).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To explore the relationship between serum microRNA-1-3p (miR-1-3p) and microRNA-155 (miR-155) levels and sarcopenia in elderly patients with type 2 diabetic nephropathy (T2DN), and the construction of prediction model. Methods A retrospective analysis was conducted on the clinical data of 192 elderly patients with T2DN admitted to our hospital from March 2024 to May 2025. The patients were divided into a sarcopenia group (n=64) and a non-sarcopenia group (n=128) based on the presence of sarcopenia. Clinical data and serum miR-1-3p and miR-155 levels were compared between the 2 groups. Logistic regression analysis was used to identify the risk factors for sarcopenia in elderly T2DN patients. A risk prediction model was constructed, and receiver operating characteristic (ROC) curve was plotted to evaluate the predictive performance of the model. SPSS statistics 27.0 and R (version 4.0.2) were employed for statistical analysis. Between-group comparison was performed using t test, χ2 test or Fisher′s exact test depending on data type. Results The sarcopenia group exhibited significantly larger proportion of aged ≥70 years and higher homeostatic model assessment of insulin resistance (HOMA-IR) levels, but lower bone mineral density, 25-hydroxyvitamin D, skeletal muscle mass index, grip strength, walking speed, Short Physical Performance Battery score, and serum miR-155 and miR-1-3p levels than in the non-sarcopenia group (P<0.05). Logistic regression analysis revealed that bone mineral density, HOMA-IR, 25-hydroxyvitamin D, miR-1-3p, and miR-155 were significantly associated with sarcopenia in elderly patients with T2DN (P<0.05). A nomogram model was constructed based on the results of multivariate analysis. Hosmer-Lemeshow test indicated sound goodness of fit of the model (χ2=4.447, P=0.815), and calibration curve analysis showed high consistency between the predicted and observed probabilities. ROC curve analysis demonstrated that the model yielded an area under the curve (AUC) of 0.970 (95%CI 0.951-0.990) for predicting sarcopenia in elderly T2DN patients, with a corrected AUC of 0.963 (95%CI 0.903-0.967) after Bootstrap internal validation. Decision curve analysis showed favorable clinical net benefit across a wide range of threshold probabilities. Conclusion The nomogram model constructed based on miR-1-3p and miR-155 demonstrates high predictive efficacy for sarcopenia in elderly patients with T2DN, providing a reliable decision-making tool for sarcopenia prediction.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 16,2025
  • Revised:
  • Adopted:
  • Online: November 11,2026
  • Published:
Article QR Code